Breast Center of New England Logo
A boutique breast imaging practice has incorporated AI-driven detection of Breast Arterial Calcification to deliver extra clinical value from routine screening mammograms.
From the beginning, our goal has been to create a breast imaging center that feels different, where women receive expert care in a welcoming environment designed around them.— Eva Lizer, Founder of Breast Center of New EnglandSAN DIEGO, CA, UNITED STATES, July 20, 2026 /EINPresswire.com/ — CureMetrix today revealed that Breast Center of New England—a women-owned breast imaging practice committed to transforming the mammography experience for women throughout New Hampshire—has adopted cmAngio®, the first FDA-cleared AI system for detecting and localizing Breast Arterial Calcification (BAC), making it the first facility in New Hampshire to deploy this technology. By identifying BAC from the same mammogram used for breast cancer screening, cmAngio provides additional clinical insight without requiring extra imaging, radiation, appointments, or time from patients.
Built on the principle that women deserve a more personal, comfortable, and empowering breast imaging experience, Breast Center of New England combines an intimate, spa-like atmosphere with advanced imaging equipment and physician-led care. By integrating cmAngio, the practice now offers a two-for-one benefit from routine screening mammograms while remaining true to its mission of delivering exceptional care that prioritizes women.
“From the beginning, our goal has been to create a breast imaging center that feels different, where women receive expert care in a welcoming environment designed around them,” said Dr. Eva Lizer, Founder and Breast Imaging Radiologist at Breast Center of New England. “By incorporating cmAngio into our screening program, we’re able to provide our patients and referring providers with important and impactful information from the mammogram they’re already receiving, while keeping the experience simple, seamless, and patient-centered.”
“Dr. Eva Lizer and her team have built a practice that puts women at the center of every decision, combining personalized care with a commitment to innovation,” said Kevin Harris, President of CureMetrix. “We’re proud to partner with Breast Center of New England to bring cmAngio to their patients and provide important clinical insights to their routine screening mammograms. It’s a great example of how AI can enhance patient care while preserving the exceptional experience Breast Center of New England is known for.”
As Breast Center of New England continues to redefine the breast imaging journey, the addition of cmAngio underscores its dedication to pairing compassionate, individualized care with innovative technology that helps women gain more from every routine mammogram.
About CureMetrix
CureMetrix is advancing women’s health through AI-powered imaging solutions designed to help clinicians detect what matters sooner. Founded in 2014 on the belief that artificial intelligence can close the gap between what medicine is capable of and what patients actually receive, CureMetrix develops precision AI that integrates into existing workflows and delivers earlier answers, greater certainty, and additional clinical insight. The company’s mission is to help save lives by improving disease detection and extending the value of screening programs worldwide. www.curemetrix.com
About Breast Center of New England
Breast Center of New England is an independent, women-owned and locally owned breast imaging practice located in Lee, New Hampshire. Its all-women team provides advanced 3D mammography, breast ultrasound, diagnostic breast imaging and bone density testing in a calm, private and supportive environment. With convenient scheduling, timely results, transparent billing and personalized physician-led care, Breast Center of New England is committed to giving patients clarity, comfort and confidence throughout their breast health journey.
CureMetrix
CureMetrix
+1 858-333-5830
email us here
Visit us on social media:
LinkedIn
Facebook
X
